Jason Campagna

Chief Medical Officer at Intercept Pharmaceuticals, Inc.

Jason Campagna

Jason Campagna

Chief Medical Officer at Intercept Pharmaceuticals, Inc.

Overview
RelSci Relationships

214

Number of Boards

1

Relationships
RelSci Relationships are individuals Jason Campagna likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder & Chief Executive Officer at Intercept Pharmaceuticals, Inc.

Relationship likelihood: Strong

Executive Vice President & General Counsel at The Medicines Co.

Relationship likelihood: Strong

Chief Executive Officer & President at IVERIC bio, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Treasurer at Intercept Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Operating Officer at Intercept Pharmaceuticals, Inc.

Relationship likelihood: Strong

Secretary & General Counsel at Intercept Pharmaceuticals, Inc.

Relationship likelihood: Strong

Owner at Intercept Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Human Resources Officer at Intercept Pharmaceuticals, Inc.

Relationship likelihood: Strong

Co-Founder & Managing Director at Mass Medical Angels LLC

Relationship likelihood: Average

Co-Founder at Translate Bio, Inc.

Relationship likelihood: Average

Paths to Jason Campagna
Potential Connections via
Relationship Science
You
Jason Campagna
Chief Medical Officer at Intercept Pharmaceuticals, Inc.
Education

The University of Miami is a private research university in Coral Gables, Florida. As of 2019, the university enrolls 17,811 students in 12 separate colleges/schools, including the Leonard M. Miller School of Medicine in Miami's Health District, a law school on the main campus, and the Rosenstiel School of Marine and Atmospheric Science focused on the study of oceanography and atmospheric sciences on Virginia Key, with research facilities at the Richmond Facility in southern Miami-Dade County. The university offers 132 undergraduate, 148 master's, and 67 doctoral degree programs, of which 63 are research/scholarship and four professional areas of study. Over the years, the university's students have represented all 50 states and close to 150 foreign countries. With more than 16,000 full- and part-time faculty and staff, UM is a top 10 employer in Miami-Dade County. UM's main campus in Coral Gables has 239 acres and over 5.7 million square feet of buildings. Research is a component of each academic division, with UM attracting $358.9 million in sponsored research grants in FY 2019. UM offers a large library system with over 3.9 million volumes and exceptional holdings in Cuban heritage and music. UM also offers a wide range of student activities, including fraternities and sororities, a student newspaper and a radio station. UM's intercollegiate athletic teams, collectively known as the Miami Hurricanes, compete in Division I of the National Collegiate Athletic Association. UM's football team has won five national championships since 1983 and its baseball team has won four national championships since 1982.

Career History
Chief Medical Officer
2019 - Current

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.

Affiliate Scholar in Residence
Current

Georgetown University is a private research university in Washington, D.C. Founded in 1789, it is the oldest Jesuit and Catholic university in the United States. Georgetown's main campus, located in Washington's Georgetown neighborhood, is noted for Healy Hall, a National Historic Landmark in the Romanesque revival style. Georgetown operates a law center on Capitol Hill and auxiliary campuses in Italy, Turkey, and Qatar.

Senior Vice President-Surgery & Perioperative Care
Prior - 2016

The Medicines Co We are a global pharmaceutical company focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. In the United States, we have three marketed products, Angiomax® (bivalirudin) for Injection, Cleviprex® (clevidipine) Injectable Emulsion, and Argatroban Injection, 50 mg per 50 mL†. We also have a pipeline of acute and intensive care hospital products in development, including three late-stage development product candidates, cangrelor, oritavancin and MDCO-157, and two early stage development product candidates, MDCO-2010 and MDCO-216. We believe that Angiomax, Cleviprex and our products in development possess favorable attributes that can satisfy unmet medical needs in the acute | intensive care hospital product market and offer, or, in the case of our products in development, have the potential to offer, improved performance to hospital businesses. The Company is publicly traded on the Nasdaq exchange under the ticker symbol MDCO. It was founded in 1996 and employs approximately 425 professionals.

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jason Campagna. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jason Campagna's profile does not indicate a business or promotional relationship of any kind between RelSci and Jason Campagna.